LINC02413

Across TCGA pan-cancer cohorts, LINC02413 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC02413 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC02413 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02413 expression acts as an unfavorable survival marker, although some lineages such as LUAD and ESCA show a favorable association.

LUAD, LGG, and UVM are the cancer types where LINC02413 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.751	0.583	<.001	63	view →
LGG	DFS	Median	All	0.668	0.802	<.001	34	view →
UVM	OS	Quartile	All	0.374	0.748	.009	31	view →
ESCA	OS	Quartile	III,IV	0.729	0.303	.001	30	view →
SKCM	OS	Median	All	0.927	0.808	.002	28	view →
UCS	DFS	Quartile	III,IV	0.133	0.493	.001	26	view →
CHOL	DFS	Quartile	All	0.807	0.183	.001	21	view →
MESO	OS	Median	All	0.645	0.451	.011	19	view →
KIRC	DFS	Quartile	All	0.547	0.773	.002	18	view →
STAD	DFS	Median	IV	0.787	0.199	.007	18	view →
BLCA	DFS	Median	IV	0.710	0.260	<.001	15	view →
THCA	DFS	Median	All	0.909	0.688	.016	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC02413–LUAD (DFS)

Open the LUAD breakdown →